SGTA: A new player in the molecular co-chaperone game

Simple item page
dc.contributor.authorPhilp, L.
dc.contributor.authorButler, M.
dc.contributor.authorHickey, T.
dc.contributor.authorButler, L.
dc.contributor.authorTilley, W.
dc.contributor.authorDay, T.
dc.date.issued2013
dc.description.abstractSmall glutamine-rich tetratricopeptide repeat-containing protein α (SGTA) is a steroid receptor molecular co-chaperone that may substantially influence hormone action and, consequently, hormone-mediated carcinogenesis. To date, published studies describe SGTA as a protein that is potentially critical in a range of biological processes, including viral infection, cell division, mitosis, and cell cycle checkpoint activation. SGTA interacts with the molecular chaperones, heat shock protein 70 (HSP70) and HSP90, and with steroid receptor complexes, including those containing the androgen receptor. Steroid receptors are critical for maintaining cell growth and differentiation in hormonally regulated tissues, such as male and female reproductive tissues, and also play a role in disease states involving these tissues. There is growing evidence that, through its interactions with chaperones and steroid receptors, SGTA may be a key player in the pathogenesis of hormonally influenced disease states, including prostate cancer and polycystic ovary syndrome. Research into the function of SGTA has been conducted in several model organisms and cell types, with these studies showing that SGTA functionality is cell-specific and tissue-specific. However, very few studies have been replicated in multiple cell types or experimental systems. Although a broad range of functions have been attributed to SGTA, there is a serious lack of mechanistic information to describe how SGTA acts. In this review, published evidence linking SGTA with hormonally regulated disease states is summarized and discussed, highlighting the need for future research to more clearly define the biological function(s) of this potentially important co-chaperone.
dc.description.statementofresponsibilityLisa K. Philp, Miriam S. Butler, Theresa E. Hickey, Lisa M. Butler, Wayne D. Tilley, Tanya K. Day
dc.identifier.citationHormones and Cancer, 2013; 4(6):343-357
dc.identifier.doi10.1007/s12672-013-0151-0
dc.identifier.issn1868-8497
dc.identifier.issn1868-8500
dc.identifier.orcidHickey, T. [0000-0002-2752-730X]
dc.identifier.orcidButler, L. [0000-0003-2698-3220]
dc.identifier.orcidTilley, W. [0000-0003-1893-2626]
dc.identifier.urihttp://hdl.handle.net/2440/81734
dc.language.isoen
dc.publisherSpringer New York LLC
dc.relation.granthttp://purl.org/au-research/grants/nhmrc/465248
dc.relation.granthttp://purl.org/au-research/grants/nhmrc/627185
dc.relation.granthttp://purl.org/au-research/grants/nhmrc/453628
dc.rights© 2013 Springer Science+Business Media New York.
dc.source.urihttps://doi.org/10.1007/s12672-013-0151-0
dc.subjectAnimals
dc.subjectHumans
dc.subjectPolycystic Ovary Syndrome
dc.subjectProstatic Neoplasms
dc.subjectSteroids
dc.subjectCarrier Proteins
dc.subjectMolecular Chaperones
dc.subjectModels, Animal
dc.subjectProtein Folding
dc.subjectFemale
dc.subjectMale
dc.titleSGTA: A new player in the molecular co-chaperone game
dc.typeJournal article
pubs.publication-statusPublished

Files

Collections

Medicine publications